These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 23573979

  • 1. Immunogenicity and protection efficacy of monomeric and trimeric recombinant SARS coronavirus spike protein subunit vaccine candidates.
    Li J, Ulitzky L, Silberstein E, Taylor DR, Viscidi R.
    Viral Immunol; 2013 Apr; 26(2):126-32. PubMed ID: 23573979
    [Abstract] [Full Text] [Related]

  • 2. Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.
    Liu YV, Massare MJ, Barnard DL, Kort T, Nathan M, Wang L, Smith G.
    Vaccine; 2011 Sep 02; 29(38):6606-13. PubMed ID: 21762752
    [Abstract] [Full Text] [Related]

  • 3. Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity.
    Du L, Zhao G, Chan CC, Sun S, Chen M, Liu Z, Guo H, He Y, Zhou Y, Zheng BJ, Jiang S.
    Virology; 2009 Oct 10; 393(1):144-50. PubMed ID: 19683779
    [Abstract] [Full Text] [Related]

  • 4. A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies.
    Faber M, Lamirande EW, Roberts A, Rice AB, Koprowski H, Dietzschold B, Schnell MJ.
    J Gen Virol; 2005 May 10; 86(Pt 5):1435-1440. PubMed ID: 15831955
    [Abstract] [Full Text] [Related]

  • 5. SARS-CoV spike proteins expressed by the vaccinia virus Tiantan strain: secreted sq protein induces robust neutralization antibody in mice.
    Yan K, Tan W, Wang H, Wang Y, Zhang X, Li Y, Ruan L.
    Viral Immunol; 2009 Feb 10; 22(1):57-66. PubMed ID: 19210229
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model.
    Du L, Zhao G, He Y, Guo Y, Zheng BJ, Jiang S, Zhou Y.
    Vaccine; 2007 Apr 12; 25(15):2832-8. PubMed ID: 17092615
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome.
    Jiang S, Bottazzi ME, Du L, Lustigman S, Tseng CT, Curti E, Jones K, Zhan B, Hotez PJ.
    Expert Rev Vaccines; 2012 Dec 12; 11(12):1405-13. PubMed ID: 23252385
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.